- Home
- PHAR vs ETJ Comparison
PHAR vs ETJ Comparison
Compare PHAR & ETJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- ETJ
- Stock Information
- Founded
- PHAR 1988
- ETJ 2007
- Country
- PHAR Netherlands
- ETJ United States
- Employees
- PHAR N/A
- ETJ N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- ETJ Finance Companies
- Sector
- PHAR Health Care
- ETJ Finance
- Exchange
- PHAR Nasdaq
- ETJ Nasdaq
- Market Cap
- PHAR 618.3M
- ETJ 623.9M
- IPO Year
- PHAR N/A
- ETJ N/A
- Fundamental
- Price
- PHAR $8.20
- ETJ $9.20
- Analyst Decision
- PHAR Strong Buy
- ETJ
- Analyst Count
- PHAR 3
- ETJ 0
- Target Price
- PHAR $27.00
- ETJ N/A
- AVG Volume (30 Days)
- PHAR 5.6K
- ETJ 175.6K
- Earning Date
- PHAR 03-13-2025
- ETJ 01-01-0001
- Dividend Yield
- PHAR N/A
- ETJ 8.30%
- EPS Growth
- PHAR N/A
- ETJ N/A
- EPS
- PHAR N/A
- ETJ N/A
- Revenue
- PHAR $285,745,000.00
- ETJ N/A
- Revenue This Year
- PHAR $20.08
- ETJ N/A
- Revenue Next Year
- PHAR $9.22
- ETJ N/A
- P/E Ratio
- PHAR N/A
- ETJ N/A
- Revenue Growth
- PHAR 30.64
- ETJ N/A
- 52 Week Low
- PHAR $6.65
- ETJ $7.20
- 52 Week High
- PHAR $13.20
- ETJ $8.47
- Technical
- Relative Strength Index (RSI)
- PHAR 36.29
- ETJ 44.49
- Support Level
- PHAR $8.49
- ETJ $9.08
- Resistance Level
- PHAR $9.35
- ETJ $9.35
- Average True Range (ATR)
- PHAR 0.55
- ETJ 0.11
- MACD
- PHAR -0.17
- ETJ -0.00
- Stochastic Oscillator
- PHAR 12.14
- ETJ 30.00
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About ETJ Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest
Eaton Vance Risk-Managed Diversified Equity Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income and gains, with a secondary objective of capital appreciation. The group invests in various sectors such as financials, healthcare, consumer discretionary, consumer staples, industrials, energy, utilities, telecommunication services, and materials.